Loading insider details...
Beta
Latest Form 4 (Aug 28, 2026): Sale of 18,300 BOLD shares, $54.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Boundless Bio, Inc. (BOLD) | Sale | 18,300 | $54.4K |
| Jul 21, 2026 | Boundless Bio, Inc. (BOLD) | Purchase | 265 | $646.60 |
| Jul 21, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Purchase | 116,671 | $415.3K |
| Jul 17, 2026 | Boundless Bio, Inc. (BOLD) | Purchase | 43,878 | $106.6K |
| Jul 15, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Purchase | 12,966 | $45.9K |
| Jul 13, 2026 | Boundless Bio, Inc. (BOLD) | Purchase | 7 | $17.36 |
| Jul 9, 2026 | Boundless Bio, Inc. (BOLD) | Purchase | 27,062 | $67.4K |
| Jul 2, 2026 | Boundless Bio, Inc. (BOLD) | Purchase | 25,930 | $65.9K |
| Jun 29, 2026 | Boundless Bio, Inc. (BOLD) | Purchase | 145,880 | $361.8K |
| Jun 3, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase | 2,299 | $35.3K |